Skip to main content
. Author manuscript; available in PMC: 2020 Aug 19.
Published in final edited form as: Pharmacotherapy. 2019 Jan;39(1):10–39. doi: 10.1002/phar.2209

Table 1.

CLSI/EUCAST Breakpoints for Colistin

Colistin MIC, mg/L
Organism Susceptible Intermediate Resistant
CLSIa
  Acinetobacter sp ≤ 2 - ≥ 4
  Pseudomonas ≤ 2 - ≥ 4
aeruginosa
EUCAST
  Acinetobacter sp ≤ 2 > 2
  P. aeruginosa ≤ 2 > 2
  Enterobacteriaceae ≤ 2 > 2

CLSI = Clinical and Laboratory Standards Institute; EUCAST = European Committee on Antimicrobial Susceptibility Testing; MIC = minimum inhibitory concentration.

a

For isolates of Enterobacter aerogenes, Enterobacter cloacae, Escherichia coli, Klebsiella pneumoniae, and Raoultella ornithinolytica, CLSI define insufficient clinical and pharmacokinetic/pharmacodynamic (PK/PD) data to set a PK/PD-based breakpoint and cite epidemiological cutoff values (ECVs) of 2 mg/L based on MIC distribution data.11, 12